Psychopharmacological aspects of antiepileptic treatment.
D000927:Anticonvulsants / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D002220:Carbamazepine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D005013:Ethosuximide / Q000627:therapeutic use; D006801:Humans; D010672:Phenytoin / Q000627:therapeutic use; D011581:Psychological Tests; D011594:Psychometrics; D011619:Psychotropic Drugs; D012107:Research Design; D012494:Sampling Studies; D013843:Thiazines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D011619:Psychotropic Drugs; D013843:Thiazines; D002220:Carbamazepine; D005013:Ethosuximide; D014635:Valproic Acid; D010672:Phenytoin